Evidence map›Paper›PMID 31794429›Full record

ArticleAging2019

The RXFP3 receptor is functionally associated with cellular responses to oxidative stress and DNA damage.

Jaana van Gastel, Hanne Leysen, Paula Santos-Otte, Jhana O Hendrickx, Abdelkrim Azmi, Bronwen Martin, Stuart Maudsley

Open access · greenAbstract read
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease.International journal of molecular sciences · 2022
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jaana van GastelReceptor Biology Lab, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Hanne LeysenReceptor Biology Lab, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Paula Santos-OtteCenter for Molecular and Cellular Bioengineering (CMCB), Technische Universität Dresden, Dresden, Germany.
Jhana O HendrickxReceptor Biology Lab, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Abdelkrim AzmiTranslational Neurobiology Group, Centre for Molecular Neuroscience, VIB, Antwerp, Belgium.
Bronwen MartinFaculty of Pharmaceutical, Veterinary and Biomedical Science, University of Antwerp, Antwerp, Belgium.
Stuart MaudsleyReceptor Biology Lab, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
University of Antwerp · BEVIB-UAntwerp Center for Molecular Neurology · BETechnische Universität Dresden · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA damage response (DDR) processes, often caused by oxidative stress, are important in aging and -related disorders. We recently showed that G protein-coupled receptor (GPCR) kinase interacting protein 2 (GIT2) plays a key role in both DNA damage and oxidative stress. Multiple tissue analyses in GIT2KO mice demonstrated that GIT2 expression affects the GPCR relaxin family peptide 3 receptor (RXFP3), and is thus a therapeutically-targetable system. RXFP3 and GIT2 play similar roles in metabolic aging processes. Gaining a detailed understanding of the RXFP3-GIT2 functional relationship could aid the development of novel anti-aging therapies. We determined the connection between RXFP3 and GIT2 by investigating the role of RXFP3 in oxidative stress and DDR. Analyzing the effects of oxidizing (H

Indexed as

DNA DamageOxidative StressCamptothecinComputational BiologyFelodipineGene Expression RegulationGene Regulatory NetworksGTPase-Activating ProteinsHEK293 CellsHumansReceptors, G-Protein-CoupledRNA, MessengerTopoisomerase I InhibitorsCamptothecinFelodipineGIT2 protein, humanGTPase-Activating ProteinsReceptors, G-Protein-CoupledRNA, MessengerRXFP3 protein, humanTopoisomerase I InhibitorsagingDNA damageGPCRrelaxin 3relaxin family peptide 3 receptor

Identifiers

PMID31794429
PMCPMC6932917
OpenAlexW2994463745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.